Schrödinger (SDGR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
22 Jun, 2026Opening remarks and agenda
Meeting called to order by CEO, with introductions of board members, management, and external representatives.
Rules of conduct and procedures for the virtual meeting were highlighted.
Corporate governance
Quorum confirmed with majority of shares present or represented by proxy.
Notice of meeting was sent to all stockholders of record as of April 23, 2026.
Shareholder proposals
Election of three Class III directors for terms ending at the 2029 annual meeting.
Advisory vote on executive compensation.
Approval of amendment to the 2022 Equity Incentive Plan to increase available shares by 3 million.
Ratification of KPMG LLP as independent registered public accounting firm for the current fiscal year.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Schrödinger
- Shifting to R&D and partnerships, with robust revenue growth and key clinical data ahead.SDGR
Jefferies London Healthcare Conference 20259 Jul 2026 - 23% revenue growth to $255.9M, strong cash, and hosted transition target positive EBITDA by 2028.SDGR
Q4 20258 Jul 2026 - Major Novartis deal and advancing clinical pipeline position the company for strong growth.SDGR
Jefferies London Healthcare Conference 20248 Jul 2026 - Q2 revenue up 35% to $47.3M; net loss $54M; Gates grant and pipeline drive growth.SDGR
Q2 20248 Jul 2026 - Novartis deal, strong software growth, and $398.4M cash offset lower drug discovery revenue.SDGR
Q3 20248 Jul 2026 - Early-stage AI and computational tools are driving growth and transforming drug discovery.SDGR
RBC Capital Markets Global Healthcare Conference 202622 May 2026 - Hosted revenue growth, product innovation, and strong customer retention drive positive outlook.SDGR
Bank of America Global Healthcare Conference 202620 May 2026 - Q1 2026 saw 12% ACV growth, strong drug discovery revenue, and a major M&A milestone.SDGR
Q1 20266 May 2026 - Board recommends approval of all proposals, including director elections and equity plan amendment.SDGR
Proxy filing28 Apr 2026